David Gorrie

Mr. David Gorrie


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in Genes
Verified
Journal Article
Open access
PDF file
DGDavid Gorrie
David Gorrie
MBMarco Bravo
Marco Bravo
LFLi Fan
Li Fan
Triptolide, a bioactive diterpene tri-epoxide extracted from Tripterygium wilfordii Hook F (TWHF), exhibits notable pharmacological activities, including anti-inflammatory, immunosuppressive, antifertility, and anticancer effects. Despite its promising therapeutic potential, clinical applications of triptolide are significantly limited by its poor water solubility and substantial toxicity, particularly hepatotoxicity, nephrotoxicity, and cardiotoxicity. These toxic effects are difficult to separate from many of its desired therapeutic effects, the Yin and Yang of triptolide applications. Triptolide’s therapeutic and toxic effects are linked to its inhibitory interactions with XPB, a DNA helicase essential for transcription by RNA polymerase II (RNAPII) and nucleotide excision repair (NER). By irreversibly binding to XPB, triptolide inhibits its ATPase activity, leading to global repression of transcription and impaired NER, which underlies its cytotoxic and antitumor properties. Recent developments, including triptolide prodrugs such as Minnelide and derivatives like glutriptolides, aim to enhance its pharmacokinetic properties and reduce toxicity. This review critically examines triptolide’s chemical structure, therapeutic applications, toxicological profile, and molecular interactions with XPB and other protein targets to inform future strategies that maximize therapeutic efficacy while minimizing adverse effects.

10 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DGDavid Gorrie
David Gorrie
Withdrawal Statement: The authors have withdrawn this manuscript because authorship disputes must be resolved. Therefore, the authors do not wish this work to be cited as a reference for the project. If you have any questions, please contact the corresponding author.

20 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DGDavid Gorrie
David Gorrie
Emiliania huxleyi is a marine microalga of great ecological importance because of its role in global carbon cycling and widespread distribution. Its long-chain fatty acids (alkenones) and nanoscale crystalline calcium carbonate shells also show promise for industrial applications like biofuels and optical circuits. Although the genome has been sequenced, these algae have no transfection system. Over half of the predicted genes in the E. huxleyi genome are of unknown function, and fundamental processes such as calcification and alkenone biosynthesis are not fully understood. We propose to develop a novel transfection system urgently needed to tap into the industrial potential of these microorganisms by unraveling the mysteries of alkenone biosynthesis and driving the overproduction of industrially useful alkenones. Cell-penetrating peptides (CPPs) are short polypeptides that can penetrate the cell membrane and translocate cargo into the cell. They are economical, easily synthesized, simple to use, and have low cytotoxicity. Herein, transfection of three related haptophyte species, E. huxleyi, Gephyrocapsa oceanica, and Isochrysis galbana was accomplished using three CPPs: antennapedia homeodomain (pAntp), transactivating transcriptional activator (TAT), and murine vascular endothelial cadherin (pVEC). After optimizing conditions and determining viability, pVEC proved superior in its transfection capabilities. These results suggest that CPPs may be a powerful tool for the genetic manipulation of haptophytes.